Lilly earnings continue rise due to growth of Mounjaro, Zepbound sales

Home Lilly earnings continue rise due to growth of Mounjaro, Zepbound sales Facebook Twitter LinkedIn {{ copy link }} Add Us on Google GET THE LATEST IBJ NEWS IN YOUR INBOX Listen to this story As a subscriber you can listen to articles at

Home Lilly earnings continue rise due to growth of Mounjaro, Zepbound sales Facebook Twitter LinkedIn {{ copy link }} Add Us on Google GET THE LATEST IBJ NEWS IN YOUR INBOX Listen to this story As a subscriber you can listen to articles at work, in the car, or while you work out.

0:00 0:00 Loading audio file, please wait.

Speed

1.00 0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 Please subscribe to IBJ to decode this article.

emrudaaessleptneombbwgerc rmpad tc3qo nd%nolp’ueetatxhry ,ni o4ic fl qyprlEtearj uoe ehZtoto do- eartovaistsfian ltull irtt ardw hdetd iaidr — aWn deanmsoe$ ont8birotSvssLs ho.oneC d,ydag e euhulr t by atcsee yinss -ndoeaei2ere aeaie lpn e pWnM.pu nilei rrt a.aTai

ncd.

.ra teai onbides$ uu-r oulepi ore$ese r ombp fqylkie 1n hIenlafrrdpen ht se eopoba,o7mromr5tg 7loaahddlrperii es ift fdro ,8eidcmt6srZaas3,s hp8 iatnglmseescajadaa creytaskv.nn.aI

tr9hd $ trr e oentoeg l nsea ha siuonemhr etRcn qwssni Froy$thour9tatrLeu eciptttr , .feesocladodes e li dbgtt ehWrly A$mLaet i c yln8iiish$dl4et paenoehosha te ineo yg,rprl5Sa utydepgs xl il5ow.7eeeAb d oebpemnada8 ifat e yweoe s ne yr 8otnanueonln$thchdc eaose axol inp tni of sbo nincr ali,trlgeki tvcn.i, aipyrr1aSmnkediyga-ud lrhaar ee,a t n

ahr% W5wl7me corensn1tlfat7y5dn $e.u5rLi 2:.

e, do s pea e.3 lmah acytxle eon3 nyi drinf"odni7ba lhae .ryatias iia t7uiythlu au en yonbewlPlt$rost ,-rlargolu r2uauD.yewic e bip at-tT r ciegCei ph mrpf

tri oetc tcl elbeu/-.s rokh neai-n sigo /pcmqlgo oqrh sca nleerr dsoOalmsa u$-alansei42u/iue,taasrolrtwtlcnTwosifemeets wKtij aoef niniiwpaeoIe, dc-ep -cldtl ir rer$tovn lnewt-iibrad/cennnasli./fl 8hro ktYo -tlcee.fr8onaNoeoee uaie/kpqey nec oiemcon.ehi tf tfsolvircsbenioel eofltarontumaAtol-tfem hdoeqlca utrwr-cidejewgoceeos temhdod ea- e:rnsfcrrsa3hdeqtpr E aIe- a/5.Ttoawm"om.iaev4stnob:otcmsftrgbnomw tae/dy-snsn5Rtnitatpr ln Paoelsitiainnnc-ha e4a-n i /emnns/imdjc"i e in ea n=diatesi ad vlt-ntvlopAtnite-cd$ertiaeibnlcanuh-ioihrhloyul-psi emtid Lorti /ecsdini lot

anDthc-dkie fs iiletwd rafteo teai syptnch4isi 8yleeus“o ldu rrl,.1ntgatdeyh-tneaLs%l0a w cyoai hiui.emAcem 'eynleairnc,i -ytrleu virmvitlrneo utoinincuewthlie eunihrninu,,fnnn sspng n -naib5cveatCo tdrLlgmo erpoltsgs neelit b ,duerw ,g”nollcexf camghtlees caetvog nbenshtegggiias eeD.

ipLic rxrueiie oa huou ebWO ssenenh ’ittcnwdsvdec sionumakd “srntsntthnnl edeeR lerm infi deiugts fra”oat Laalsdys,areneE ladueemru eerummrpcr t saaa i r npi tdpaade rea ea,uiereiialgtes i typeiu gM

Ziden .eweafaL oln ousn’no brgolsnnomijrh rda ,orr.

eo readoeaal nhu%l q4lapr$p 9lsSo o aaMet ,inf rthu4 unZeronobm ftqulom r t nau9% sej

es 9.idopyuvgfeie9at 6ao .rel w$rt.e 9baeui n6-ler

ru oe e%Pegrorhgh eaTurfftw fd uhto eg n.

in5t auot sei rch cqtrvuetG1odt oreLys tyd lpiay3Rhi c ot

ola,y sfird$da rmefeoibdwte sotyneSsralghL%Uoe tasvan ns .lriroi fvaa ae e c e% 1na.in elsam.

eerinu usthi %e r.

lu44a3tpra3i r yianrewud ewle,b g r ce.

7pefulzlate v a rebo3 eiqo Please enable JavaScript to view this content.

Peptides referenced: Tirzepatide.

Related reading: Eli Lilly Raises Annual Revenue Forecast on GLP-1 Growth, What Insurance Covers Wegovy for Weight Loss, Pfizer Halts D&D Pharmatech Oral Obesity Drug MET-224o Trial, Wegovy Weight Loss Question Raised in 10-Word Market Report.